Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India
· Delayed Price · Currency is INR 2,117.60
-6.80 (-0.32%)
At close: Mar 9, 2026
Glenmark Pharmaceuticals Revenue
Glenmark Pharmaceuticals had revenue of 39.01B INR in the quarter ending December 31, 2025, with 15.15% growth. This brings the company's revenue in the last twelve months to 165.10B, up 18.26% year-over-year. In the fiscal year ending March 31, 2025, Glenmark Pharmaceuticals had annual revenue of 133.63B with 5.68% growth.
Revenue (ttm)
165.10B
Revenue Growth
+18.26%
P/S Ratio
3.62
Revenue / Employee
10.45M
Employees
15,800
Market Cap
597.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 133.63B | 7.18B | 5.68% |
| Mar 31, 2024 | 126.45B | 9.90B | 8.49% |
| Mar 31, 2023 | 116.56B | -6.49B | -5.28% |
| Mar 31, 2022 | 123.05B | 13.61B | 12.44% |
| Mar 31, 2021 | 109.44B | 2.87B | 2.69% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Laurus Labs | 67.22B |
| Alkem Laboratories | 142.53B |
| Aurobindo Pharma | 331.82B |
| Mankind Pharma | 139.14B |
| Zydus Lifesciences | 260.89B |
| Ipca Laboratories | 95.06B |
| Ajanta Pharma | 52.02B |
| Cipla | 279.67B |
Glenmark Pharmaceuticals News
- 20 hours ago - Pharma sector fall sharply otday, March 9: Laurus Labs down 3%, Glenmark Pharma drops 2.44%, Zydus Life falls 2.10% - Business Upturn
- 5 days ago - Glenmark Pharma subsidiary gets US FDA approves Fluticasone Propionate inhalation aerosol with 180-day exclusivity - Business Upturn
- 10 days ago - Glenmark Pharma’s US arm to launch Sodium Phosphates Injection USP - Business Upturn
- 4 weeks ago - Pharma sector stocks today, Feb 9: Marksans Pharma up 5%, Shilpa Medicare jumps 6%, Glenmark rises 1.83% - Business Upturn
- 6 weeks ago - AcuCort Signs Glenmark Deal To Market Zeqmelit In Six European Countries - Nasdaq
- 6 weeks ago - Pharma sector stocks fall today: Glenmark Pharma drops 1.38%, Aurobindo Pharma downm 1.25%, Sun Pharma falls 0.87, Dr. Reddy’s Lab down 0.48% - Business Upturn
- 7 weeks ago - Pharma sector stocks today: Sun Pharma falls 1.20%, Lupin down 1%, Glenmark Pharma rises 0.49% - Business Upturn
- 7 weeks ago - Pharma sector stocks today: Glenmark Pharma falls 2.41%, Dr Reddy’s Laboratories down 1.39%, Emcure up 1.70% - Business Upturn